A Study Investigating the Safety of a Clostridium difficile Vaccine in Subjects 65 to 85 Years of Age

A Phase 2, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Health Adults Aged 65 to 85 Years

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06425090
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B5091009
Open Plain Language Summary Result:Click here